Proteon Therapeutics Inc. Secures $38,000,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=59912525-3ffa-4b5e-a87d-a1498c36cbe1&Preview=1 - Date
3/5/2009 - Company Name
Proteon Therapeutics Inc. - Mailing Address
200 West Street Waltham, MA 02451 - Company Description
Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring. - Website
http://www.proteontherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$38,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
MPM Capital - Venture Investor
Undisclosed - Venture Investor
TVM Capital - Venture Investor
Skyline Ventures - Venture Investor
Prism VentureWorks - Venture Investor
Intersouth Partners
